Genomic & Biopharma NewsHuman Gut Microbe Transplant Alters Mouse Behavior
Fecal transplants from humans with irritable bowel syndrome and anxiety into mice lead to similar symptoms and anxiety-like behavior in the rodents, researchers report.
|The Scientist, 2017-03-01 20:00:00|
Metrion teams up with Assay.Works in ion channel drug discovery services
Metrion teams up with Assay.Works in ion channel drug discovery services aliu Wed, 03/01/2017 - 14:00
|Fierce Biotech, 2017-03-01 19:00:52|
Allergan expanding manufacturing sites in Ireland
Allergan expanding manufacturing sites in Ireland epalmer Wed, 03/01/2017 - 13:13
|Fierce Pharma, 2017-03-01 18:13:05|
Nature can beat back scientific tinkering with genes of entire species
Scientists have revealed daunting challenges to changing the DNA of entire populations of species via the most promising techniques available today to produce 'gene drive.'
|ScienceDaily, 2017-03-01 18:05:11|
Athletes’ anxiety over illness symptoms could increase injury risk
The anxiety experienced by elite athletes over illness symptoms is linked to the risk of being injured during competition and should be taken seriously, according to a study carried out at the IAAF World Championships in Athletics 2015.
|News Medical Life Sciences, 2017-03-01 17:32:17|
Commonly-prescribed drug for treating weak bone condition linked to increased risk of 'micro-cracks'
A type of drug used to treat weak bones is associated with an increased risk of 'micro-cracks' in bone, according to new research.
|News Medical Life Sciences, 2017-03-01 16:53:14|
Immune system defect makes Addison’s patients prone to respiratory infections
Research led by University of Birmingham scientists has found that people suffering from the adrenal disorder known as Addison's disease suffer from an immune system defect which makes them prone to potentially deadly respiratory infections.
|News Medical Life Sciences, 2017-03-01 16:45:14|
Sutent, Immunotherapy Combo Significantly Reduces Tumor Growth in HCC Mouse Model
|Immuno-Oncology News, 2017-03-01 16:35:13|
Study finds new drug treatment to be safe and well-tolerated in pediatric patients with anxiety
A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary evidence of its potential effectiveness.
|News Medical Life Sciences, 2017-03-01 16:27:25|